• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于X射线结构鉴定对不同家族靶点具有活性的化合物并生成多靶点配体设计模板

X-ray-Structure-Based Identification of Compounds with Activity against Targets from Different Families and Generation of Templates for Multitarget Ligand Design.

作者信息

Gilberg Erik, Stumpfe Dagmar, Bajorath Jürgen

机构信息

Department of Life Science Informatics, B-IT, LIMES Program Unit Chemical Biology and Medicinal Chemistry, Rheinische Friedrich-Wilhelms-Universität, Dahlmannstr. 2, D-53113 Bonn, Germany.

Pharmaceutical Institute, Rheinische Friedrich-Wilhelms-Universität, An der Immenburg 4, D-53121 Bonn, Germany.

出版信息

ACS Omega. 2018 Jan 31;3(1):106-111. doi: 10.1021/acsomega.7b01849. Epub 2018 Jan 5.

DOI:10.1021/acsomega.7b01849
PMID:30023769
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6045467/
Abstract

Compounds with multitarget activity (promiscuity) are increasingly sought in drug discovery. However, promiscuous compounds are often viewed controversially in light of potential assay artifacts that may give rise to false-positive activity annotations. We have reasoned that the strongest evidence for true multitarget activity of small molecules would be provided by experimentally determined structures of ligand-target complexes. Therefore, we have carried out a systematic search of currently available X-ray structures for compounds forming complexes with different targets. Rather unexpectedly, 1418 such crystallographic ligands were identified, including 702 that formed complexes with targets from different protein families (multifamily ligands). About half of these multifamily ligands originated from the medicinal chemistry literature, making it possible to consider additional target annotations and search for analogues. From 168 distinct series of analogues containing one or more multifamily ligands, 133 unique analogue-series-based scaffolds were isolated that can serve as templates for the design of new compounds with multitarget activity. As a part of our study, all of the multifamily ligands we have identified and the analogue-series-based scaffolds are made freely available.

摘要

在药物研发中,具有多靶点活性(混杂性)的化合物越来越受到关注。然而,鉴于可能导致假阳性活性注释的潜在检测假象,混杂性化合物常常受到争议。我们推断,小分子真正多靶点活性的最有力证据将来自于实验确定的配体-靶点复合物结构。因此,我们对目前可用的X射线结构进行了系统搜索,以寻找与不同靶点形成复合物的化合物。相当出乎意料的是,我们鉴定出了1418种这样的晶体学配体,其中包括702种与来自不同蛋白质家族的靶点形成复合物的配体(多家族配体)。这些多家族配体中约有一半来自药物化学文献,这使得考虑额外的靶点注释并搜索类似物成为可能。从包含一个或多个多家族配体的168个不同系列类似物中,分离出了133种基于独特类似物系列的支架,这些支架可作为设计具有多靶点活性新化合物的模板。作为我们研究的一部分,我们鉴定出的所有多家族配体以及基于类似物系列的支架均可免费获取。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1937/6645757/537a867cc0b7/ao-2017-01849e_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1937/6645757/b239703fd1ce/ao-2017-01849e_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1937/6645757/537a867cc0b7/ao-2017-01849e_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1937/6645757/b239703fd1ce/ao-2017-01849e_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1937/6645757/537a867cc0b7/ao-2017-01849e_0002.jpg

相似文献

1
X-ray-Structure-Based Identification of Compounds with Activity against Targets from Different Families and Generation of Templates for Multitarget Ligand Design.基于X射线结构鉴定对不同家族靶点具有活性的化合物并生成多靶点配体设计模板
ACS Omega. 2018 Jan 31;3(1):106-111. doi: 10.1021/acsomega.7b01849. Epub 2018 Jan 5.
2
Promiscuous Ligands from Experimentally Determined Structures, Binding Conformations, and Protein Family-Dependent Interaction Hotspots.来自实验确定结构、结合构象和蛋白质家族依赖性相互作用热点的混杂配体。
ACS Omega. 2019 Jan 22;4(1):1729-1737. doi: 10.1021/acsomega.8b03481. eCollection 2019 Jan 31.
3
Identifying Promiscuous Compounds with Activity against Different Target Classes.鉴定对不同靶类具有活性的泛型化合物。
Molecules. 2019 Nov 18;24(22):4185. doi: 10.3390/molecules24224185.
4
Biological Activity Profiles of Multitarget Ligands from X-ray Structures.从 X 射线结构看多靶点配体的生物活性谱
Molecules. 2020 Feb 12;25(4):794. doi: 10.3390/molecules25040794.
5
X-ray Structure-Based Chemoinformatic Analysis Identifies Promiscuous Ligands Binding to Proteins from Different Classes with Varying Shapes.基于 X 射线结构的化学信息学分析鉴定了与不同形状的不同类别蛋白质结合的多功能配体。
Int J Mol Sci. 2020 May 27;21(11):3782. doi: 10.3390/ijms21113782.
6
Systematic Data Analysis and Diagnostic Machine Learning Reveal Differences between Compounds with Single- and Multitarget Activity.系统数据分析和诊断机器学习揭示具有单靶点和多靶点活性的化合物之间的差异。
Mol Pharm. 2020 Dec 7;17(12):4652-4666. doi: 10.1021/acs.molpharmaceut.0c00901. Epub 2020 Nov 5.
7
Rationalizing Promiscuity Cliffs.合理化混杂峭壁。
ChemMedChem. 2018 Mar 20;13(6):490-494. doi: 10.1002/cmdc.201700535. Epub 2017 Nov 6.
8
Activity cliffs produced by single-atom modification of active compounds: Systematic identification and rationalization based on X-ray structures.单原子修饰活性化合物产生的活性悬崖:基于 X 射线结构的系统识别和合理化。
Eur J Med Chem. 2020 Dec 1;207:112846. doi: 10.1016/j.ejmech.2020.112846. Epub 2020 Sep 16.
9
X-ray Structures of Target-Ligand Complexes Containing Compounds with Assay Interference Potential.含有具有检测干扰潜力的化合物的靶标-配体复合物的 X 射线结构。
J Med Chem. 2018 Feb 8;61(3):1276-1284. doi: 10.1021/acs.jmedchem.7b01780. Epub 2018 Jan 24.
10
Prediction of Promiscuity Cliffs Using Machine Learning.使用机器学习预测滥交悬崖。
Mol Inform. 2021 Jan;40(1):e2000196. doi: 10.1002/minf.202000196. Epub 2020 Sep 29.

引用本文的文献

1
Polyphenolic promiscuity, inflammation-coupled selectivity: Whether PAINs filters mask an antiviral asset.多酚的混杂性、炎症耦合选择性:“PAINs”过滤器是否掩盖了一种抗病毒特性。
Front Pharmacol. 2022 Oct 21;13:909945. doi: 10.3389/fphar.2022.909945. eCollection 2022.
2
Advances in Computational Polypharmacology.计算多药理学进展。
Mol Inform. 2022 Dec;41(12):e2200190. doi: 10.1002/minf.202200190. Epub 2022 Sep 6.
3
Gains from no real PAINS: Where 'Fair Trial Strategy' stands in the development of multi-target ligands.

本文引用的文献

1
Computational design of new molecular scaffolds for medicinal chemistry, part II: generalization of analog series-based scaffolds.药物化学新分子骨架的计算设计,第二部分:基于类似物系列的骨架的推广
Future Sci OA. 2017 Nov 30;4(2):FSO267. doi: 10.4155/fsoa-2017-0102. eCollection 2018 Feb.
2
How Frequently Are Pan-Assay Interference Compounds Active? Large-Scale Analysis of Screening Data Reveals Diverse Activity Profiles, Low Global Hit Frequency, and Many Consistently Inactive Compounds.泛分析干扰化合物的出现频率有多高?大规模筛选数据的分析揭示了多样化的活性特征、低的全球命中频率以及许多始终不活跃的化合物。
J Med Chem. 2017 May 11;60(9):3879-3886. doi: 10.1021/acs.jmedchem.7b00154. Epub 2017 Apr 25.
3
无实际痛苦的收获:“公平试验策略”在多靶点配体开发中的地位。
Acta Pharm Sin B. 2021 Nov;11(11):3417-3432. doi: 10.1016/j.apsb.2021.02.023. Epub 2021 Mar 4.
4
Introducing the metacore concept for multi-target ligand design.引入用于多靶点配体设计的元核心概念。
RSC Med Chem. 2021 Apr 15;12(4):628-635. doi: 10.1039/d1md00056j. eCollection 2021 Apr 28.
5
Multiple Target Drug Design Using LigBuilder 3.使用LigBuilder 3进行多靶点药物设计。
Methods Mol Biol. 2021;2266:279-298. doi: 10.1007/978-1-0716-1209-5_16.
6
Analysis of Biological Screening Compounds with Single- or Multi-Target Activity via Diagnostic Machine Learning.基于诊断机器学习的单靶点或多靶点生物筛选化合物分析。
Biomolecules. 2020 Nov 27;10(12):1605. doi: 10.3390/biom10121605.
7
X-ray Structure-Based Chemoinformatic Analysis Identifies Promiscuous Ligands Binding to Proteins from Different Classes with Varying Shapes.基于 X 射线结构的化学信息学分析鉴定了与不同形状的不同类别蛋白质结合的多功能配体。
Int J Mol Sci. 2020 May 27;21(11):3782. doi: 10.3390/ijms21113782.
8
Biological Activity Profiles of Multitarget Ligands from X-ray Structures.从 X 射线结构看多靶点配体的生物活性谱
Molecules. 2020 Feb 12;25(4):794. doi: 10.3390/molecules25040794.
9
Data structures for computational compound promiscuity analysis and exemplary applications to inhibitors of the human kinome.计算化合物混杂分析的数据结构及其在人类激酶组抑制剂中的应用实例
J Comput Aided Mol Des. 2020 Jan;34(1):1-10. doi: 10.1007/s10822-019-00266-0. Epub 2019 Dec 2.
10
Identifying Promiscuous Compounds with Activity against Different Target Classes.鉴定对不同靶类具有活性的泛型化合物。
Molecules. 2019 Nov 18;24(22):4185. doi: 10.3390/molecules24224185.
The Ecstasy and Agony of Assay Interference Compounds.
分析干扰化合物的喜与忧
J Chem Inf Model. 2017 Mar 27;57(3):387-390. doi: 10.1021/acs.jcim.7b00105. Epub 2017 Feb 28.
4
Phantom PAINS: Problems with the Utility of Alerts for Pan-Assay INterference CompoundS.幻痛:泛分析干扰化合物警报的效用问题
J Chem Inf Model. 2017 Mar 27;57(3):417-427. doi: 10.1021/acs.jcim.6b00465. Epub 2017 Feb 25.
5
Analog series-based scaffolds: computational design and exploration of a new type of molecular scaffolds for medicinal chemistry.基于类似物系列的支架:用于药物化学的新型分子支架的计算设计与探索
Future Sci OA. 2016 Oct 4;2(4):FSO149. doi: 10.4155/fsoa-2016-0058. eCollection 2016 Dec.
6
UniProt: the universal protein knowledgebase.通用蛋白质知识库:UniProt
Nucleic Acids Res. 2017 Jan 4;45(D1):D158-D169. doi: 10.1093/nar/gkw1099. Epub 2016 Nov 29.
7
Highly Promiscuous Small Molecules from Biological Screening Assays Include Many Pan-Assay Interference Compounds but Also Candidates for Polypharmacology.来自生物筛选试验的高度混杂小分子包含许多泛分析干扰化合物,但也有多重药理学的候选物。
J Med Chem. 2016 Nov 23;59(22):10285-10290. doi: 10.1021/acs.jmedchem.6b01314. Epub 2016 Nov 3.
8
Computational Method for the Systematic Identification of Analog Series and Key Compounds Representing Series and Their Biological Activity Profiles.用于系统鉴定模拟系列以及代表系列的关键化合物及其生物活性谱的计算方法。
J Med Chem. 2016 Aug 25;59(16):7667-76. doi: 10.1021/acs.jmedchem.6b00906. Epub 2016 Aug 8.
9
Multitarget Drug Discovery and Polypharmacology.多靶点药物发现与多药理学
ChemMedChem. 2016 Jun 20;11(12):1190-2. doi: 10.1002/cmdc.201600161. Epub 2016 Apr 9.
10
Structural insights into xenobiotic and inhibitor binding to human aldehyde oxidase.结构洞察异生物和抑制剂与人醛氧化酶的结合。
Nat Chem Biol. 2015 Oct;11(10):779-83. doi: 10.1038/nchembio.1895. Epub 2015 Aug 31.